Home/ Supplements/ D Aspartic Acid/ DAA D-Aspartic Acid Unflavored Powder

DAA D-Aspartic Acid Unflavored Powder

product on market Powder Staunch Labs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for DAA D-Aspartic Acid Unflavored Powder
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Gram(s)
Serving Size
50
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

3 Gram(s)
Market median: 2000.0mg (63 products)

Other Ingredients

None
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, mix 1 scoop with 6-10 ounces of water.

Warnings & Precautions

Warning: This product is only intended to be consumed by healthy individuals 18 years of age or older. Keep out of reach of children.

Consult your physician prior to use if you are pregnant or nursing.

Do not exceed directed use. Improper use will not improve results and is not advised. Do not use if safety seal is broken.

Formulation Notes

3G Per serving 150G Per container

Dietary Supplement

Additional Information

Storage: Product is filled by weight not volume, some settling may occur.

To keep product fresh and prevent clumping, store tightly-closed in a cool, dry place.

Metadata

Product Details

UPC / SKU7 13325 96006 4
DSLD Entry Date2023-09-25
Product TypeAmino acid/Protein
FormPowder
DSLD ID297702
Data Updated2026-04-11
Research

Research Evidence

9
Research Sources
37
Avg Quality
5
Rct
4
Other
C The Effects of Six-Gram D-Aspartic Acid Supplementation on the Testosterone, Cortisol, and Hematological Responses of Male Boxers Subjected to 11 Days of Nocturnal Exposure to Normobaric Hypoxia
Rct Nutrients 2023 PubMed DOI
C Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
Rct Journal of psychopharmacology (Oxford, England) 2012 PubMed DOI
C The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial
Rct PloS one 2017 PubMed DOI
C Short-Term d-Aspartic Acid Supplementation Does Not Affect Serum Biomarkers Associated With the Hypothalamic-Pituitary-Gonadal Axis in Male Climbers
Rct International journal of sport nutrition and exercise metabolism 2019 PubMed DOI
C Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis
Other Neuroscience letters 2021 PubMed DOI
D A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain
Rct Anesthesia and analgesia 2004 PubMed DOI
D The efficacy of adrenocorticotropic hormone in a girl with anti-N-methyl-D-aspartate receptor encephalitis
Other Brain & development 2018 PubMed DOI
D The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats
Other Reproductive biology and endocrinology : RB&E 2009 PubMed DOI
F Blockage of N-methyl-D-aspartate receptors decreases testosterone levels and enhances postnatal neuronal apoptosis in the preoptic area of male rats
Other Neuroendocrinology 2000 PubMed
View all evidence for D Aspartic Acid →
Compare

Similar Products

View all D Aspartic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.